Pharmaco-fUS for Characterizing Drugs for Alzheimer’s Disease – The Case of THN201, a Drug Combination of Donepezil Plus Mefloquine

Donepezil is a potent acetylcholinesterase inhibitor, largely used worldwide to alleviate cognitive symptoms in Alzheimer’s disease (AD). Beyond the widely described neuronal impact of donepezil, it was recently shown that targeting connexins, the proteins involved in astrocyte network organization,...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidal, Benjamin, Droguerre, Marine, Valdebenito, Marco, Zimmer, Luc, Hamon, Michel, Mouthon, Franck, Charvériat, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437134/
https://www.ncbi.nlm.nih.gov/pubmed/32903470
http://dx.doi.org/10.3389/fnins.2020.00835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437134/
https://www.ncbi.nlm.nih.gov/pubmed/32903470
http://dx.doi.org/10.3389/fnins.2020.00835

Ejemplares similares